Clinical Trial Update: Growth Hormone in a Patient With a Dominant-Negative GHR Mutation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating growth hormone treatment in a patient with a dominant-negative growth hormone receptor mutation. Results were posted on 2025-07-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Growth Hormone Insensitivity Syndrome
• Laron Syndrome

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Children's National Research Institute | Conditions: Growth Disorders | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-02